EU FALSIFIED MEDICINES DIRECTIVE
THE COUNTDOWN TO FMD COMPLIANCE IS UNDERWAY
Getting ready for Falsified Medecines Directives (FMD) compliance can be a complex process. Avoid supply interruption. Make sure you have a robust, realistic plan to meet the February 9, 2019 EU FMD compliance deadline.
Less than two years remain ─ will you be ready in time? With 32 countries across Europe being affected by this serialization legislation, the entire industry must prepare. This webinar will help ensure you have a solid, comprehensive strategy and implementation plan in place before it is too late.
Without an effective plan, you risk facing significant product supply issues once the deadline is enforced. Join Be4ward, OPTEL and Verify Brand for this informative webinar.
Learn how to:
- Develop an effective strategy for EU FMD compliance with low risk to your business
- Implement your EU FMD plan with minimal impact to your resources
- Identify key solutions, specially designed for rapid implementation
Speaker Name: Jean-Pierre Allard.
Title: Chief Technology Officer
Organization: OPTEL GROUP
Speaker Name: Stephen McIndoe
Title: Serialisation Practice VP
Since 1999, Stephen has helped many pharma and biotech companies and their supply chain partners to define and implement end-to-end serialisation capabilities to both meet legislative requirements and deliver other business benefits. Stephen heads the serialisation practice at Be4ward, managing a group of specialists offering independent advice through a combination of deep subject matter expertise and excellent consulting skills.
Speaker Name: Dhermita Desai Mulchandani
Title: Senior Project Manager, UK and EU
Dhermita Desai’s operational skills have been honed through 16 years of work in the Life Sciences industry, where she has authored validation documents and has helped onboard more than 100 trading partner CPOs and CMOs. As a senior project manager at Verify Brand, Dhermita leverages her knowledge of EU FMD serialization and the critical role CMOs and CPOs play in the interoperability of pharmaceutical value chains to ensure that her clients’ serialization projects meet regulatory market and business requirements. Dhermita’s previous experience includes quality and program management roles at Amdipharm Mercury Company, Mercury Pharma, Lexon UK and Reckitt Benckiser Healthcare International. She views constantly evolving regulatory compliance mandates as tremendous opportunities to leverage her organizational and management skills to ensure that her clients’ serialization projects meet regulatory market and business requirements. Dhermita has a degree from De Montfort University in Pharmaceutical Chemistry.